Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis — Erawan Borkham‐Kamphorst (2004) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
RW
Shared by
Ralf Weiskirchen
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
Article
2004
en
Authors
+3 more
EB
Erawan Borkham‐Kamphorst
JH
Jens Herrmann
DS
Doris Stoll
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway.
Ralf Weiskirchen
Article
2004
Inhibitory effect of soluble PDGF-β receptor in culture-activated hepatic stellate cells
Erawan Borkham‐Kamphorst
,
Doris Stoll
,
Axel M. Gressner
,
Ralf Weiskirchen
Article
2023
Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation
Yulia A. Nevzorova
,
Ralf Weiskirchen
,
Christian Liedtke
Article
2016
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer
Ángeles Durán
,
Eloy D. Hernandez
,
Miguel Reina‐Campos
,
Elias A. Castilla
,
Shankar Subramaniam
,
Sindhu Raghunandan
,
Lewis R. Roberts
,
Tatiana Kisseleva
,
Michael Karin
,
María T. Díaz‐Meco
,
Jorge Moscat
Dataset
Faculty Opinions recommendation of β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis.
Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.